These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 24879926

  • 1. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
    Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, Loftus EV, Peyrin-Biroulet L, Blonski WC, Van Domselaar M, Chaparro M, Sandilya S, Bewtra M, Beigel F, Biancone L, Lichtenstein GR.
    Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
    [Abstract] [Full Text] [Related]

  • 2. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
    Khan N, Abbas AM, Lichtenstein GR, Loftus EV, Bazzano LA.
    Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
    Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD.
    Gut; 2005 Aug; 54(8):1121-5. PubMed ID: 16009685
    [Abstract] [Full Text] [Related]

  • 4. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis.
    Jess T, Lopez A, Andersson M, Beaugerie L, Peyrin-Biroulet L.
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1793-1800.e1. PubMed ID: 24907505
    [Abstract] [Full Text] [Related]

  • 5. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
    Lopez A, Mounier M, Bouvier AM, Carrat F, Maynadié M, Beaugerie L, Peyrin-Biroulet L, CESAME Study Group.
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
    [Abstract] [Full Text] [Related]

  • 6. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED.
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [Abstract] [Full Text] [Related]

  • 7. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
    Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE.
    Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
    [Abstract] [Full Text] [Related]

  • 8. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 9. Azathioprine and mercaptopurine: lymphoma.
    Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.
    Teruel C, López-San Román A, Bermejo F, Taxonera C, Pérez-Calle JL, Gisbert JP, Martín-Arranz M, Ponferrada A, Van Domselaar M, Algaba A, Estellés J, López-Serrano P, Linares PM, Muriel A.
    Am J Gastroenterol; 2010 Sep; 105(9):2003-8. PubMed ID: 20700117
    [Abstract] [Full Text] [Related]

  • 12. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
    Ariyaratnam J, Subramanian V.
    Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479
    [Abstract] [Full Text] [Related]

  • 13. Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.
    Chupin A, Perduca V, Meyer A, Bellanger C, Carbonnel F, Dong C.
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1289-1297. PubMed ID: 32840893
    [Abstract] [Full Text] [Related]

  • 14. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
    Beigel F, Steinborn A, Schnitzler F, Tillack C, Breiteneicher S, John JM, Van Steen K, Laubender RP, Göke B, Seiderer J, Brand S, Ochsenkühn T.
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):735-44. PubMed ID: 24788825
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L, Tata LJ, Fiaschi L, Card T.
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [Abstract] [Full Text] [Related]

  • 17. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.
    Vos AC, Bakkal N, Minnee RC, Casparie MK, de Jong DJ, Dijkstra G, Stokkers P, van Bodegraven AA, Pierik M, van der Woude CJ, Oldenburg B, Hommes DW, Initiative on Crohn's and Colitis (ICC).
    Inflamm Bowel Dis; 2011 Sep; 17(9):1837-45. PubMed ID: 21830262
    [Abstract] [Full Text] [Related]

  • 18. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    van Schaik FD, van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B.
    Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
    [Abstract] [Full Text] [Related]

  • 19. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, De Teresa-Galván J, Redondo-Cerezo E.
    World J Gastroenterol; 2013 Aug 14; 19(30):4877-86. PubMed ID: 23946592
    [Abstract] [Full Text] [Related]

  • 20. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe.
    Lakatos PL, Lovasz BD, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Vegh Z, Mandel M, Horvath A, Szathmari M, Kiss LS, Lakatos L.
    J Crohns Colitis; 2013 Jun 14; 7(5):385-91. PubMed ID: 22766526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.